You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

List of Excipients in API LEVONORGESTREL


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing LEVONORGESTREL

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Allergan Inc LILETTA levonorgestrel 0023-5858 BARIUM SULFATE
Allergan Inc LILETTA levonorgestrel 0023-5858 DIMETHICONE
Rebel Distributors Corp PLAN B ONE-STEP levonorgestrel 21695-973 LACTOSE MONOHYDRATE
Rebel Distributors Corp PLAN B ONE-STEP levonorgestrel 21695-973 MAGNESIUM STEARATE
Rebel Distributors Corp PLAN B ONE-STEP levonorgestrel 21695-973 SILICON DIOXIDE
Rebel Distributors Corp PLAN B ONE-STEP levonorgestrel 21695-973 STARCH, CORN
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing LEVONORGESTREL

Company Ingredient NDC Excipient
L Perrigo Company levonorgestrel 0113-2003 LACTOSE MONOHYDRATE
L Perrigo Company levonorgestrel 0113-2003 MAGNESIUM STEARATE
L Perrigo Company levonorgestrel 0113-2003 POVIDONE
L Perrigo Company levonorgestrel 0113-2003 SILICON DIOXIDE
L Perrigo Company levonorgestrel 0113-2003 STARCH, CORN
Rugby Laboratories levonorgestrel 0536-1142 HYPROMELLOSE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for LEVONORGESTREL

Excipient focus: BARIUM SULFATE

Excipient focus: CAPRIC ACID

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: COPOVIDONE K25-31

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: DIMETHICONE

Excipient focus: DIMETHYL SULFOXIDE

Excipient focus: ETHYL LACTATE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 5

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: GELATIN

Excipient focus: HEPTANE

Excipient focus: HYDROGENATED COTTONSEED OIL

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LAURYL LACTATE

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: MAGNESIUM STEARATE

Excipient focus: NITROGEN

Excipient focus: POLACRILIN POTASSIUM

Excipient focus: POLOXAMER 188

Excipient focus: POLYBUTENE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3000

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYISOBUTYLENE

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: POVIDONE K25

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: SILICON DIOXIDE

Excipient focus: STARCH, CORN

Excipient focus: STARCH, POTATO

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

LEVONORGESTREL drug variants containing TITANIUM DIOXIDE

Company Ingredient NDC
Northstar Rx LLC levonorgestrel 16714-809
Ingenus Pharmaceuticals LLC levonorgestrel 50742-352
HRA Pharma America Inc levonorgestrel 73302-911
Central Texas Community Health Centers levonorgestrel 76413-357
Ingenus Pharmaceuticals LLC levonorgestrel and ethinyl estradiol 50742-659
Glenmark Pharmaceuticals Inc USA levonorgestrel and ethinyl estradiol 68462-637
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group